Postoperative radiotherapy and chemotherapy in the management of oligodendroglioma: Single institutional review of 88 patients

Journal of Neuro-Oncology

Volumn 75, Issue 2, 2005, Pages 189-193

  Ozyigit, Gokhan ^a   Onal, Cem ^a   Gurkaynak, Murat ^a   Soylemezoglu, Figen ^a   Zorlu, Faruk ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; Oligodendroglioma; Radiotherapy

Indexed keywords

TEMOZOLOMIDE;

ADOLESCENT; ADULT; AGED; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OLIGODENDROGLIOMA; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BRAIN NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 29244478284     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-2057-3     Document Type: Review

References (27)

1. Daumas-Duport C, Tucker ML, Kolles H et al.: Oligodendrogliomas Part II: a new grading system based on morphological and imaging criteria. J Neurooncol 34: 61-78, 1997
2. Mason WP, Krol GS, DeAngelis LM: Low-grade oligodendroglioma responds to chemotherapy. Neurology 46: 203-207, 1996
3. Coons SW, Johnson PC, Scheithauer BW et al.: Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79: 1381-1393, 1997
4. Engelhard HH, Stelea A, Cochran EJ: Oligodendroglioma: pathology and molecular biology. Surg Neurol 58: 111-117, 2002discussion 117, 2002
5. Jukich PJ. McCarthy BJ, Surawicz TS et al.: Trends in incidence of primary brain tumors in the United States, 1985-1994. Neurooncology 3: 141-151, 2001
6. Fortin D, Macdonald DR, Stitt L, Cairncross JG: PCV for oligodendroglial tumors: in search of prognostic factors for response and survival. Can J Neurol Sci 28: 215-223, 2001
7. Kros JM, Pieterman H, van Eden CG et al.: Oligodendroglioma: the Rotterdam-Dijkzigt experience. Neurosurgery 34: 959-966, 1994discussion 966, 1994
8. Shaw EG, Scheithauer BW, O'Fallon JR et al.: Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg 76: 428-434, 1992
9. Celli P, Nofrone I, Palma L et al.: Cerebral oligodendroglioma: prognostic factors and life history. Neurosurgery 35: 1018-1034, 1994discussion 1034-1015, 1994
10. Bouffet E, Jouvet A, Thiesse P et al.: Chemotherapy for aggressive or anaplastic high grade oligodendrogliomas and oligoastrocytomas: better than a salvage treatment. Br J Neurosurg 12: 217-222, 1998
11. van den Bent MJ, Kros JM, Heimans JJ et al.: Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy Dutch Neurooncology Group. Neurology 51: 1140-1145, 1998
12. Dehghani F, Schachenmayr W, Laun A et al.: Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases. Acta Neuropathol (Berl) 95: 493-504, 1998
13. Shimizu KT, Tran LM, Mark RJ et al.: Management of oligodendrogliomas. Radiology 186: 569-572, 1993
14. Allam A, Radwi A, El Weshi A et al.: Oligodendroglioma: an analysis of prognostic factors and treatment results. Am J Clin Oncol 23: 170-175, 2000
15. Gannett DE, Wisbeck WM, Silbergeld DL et al.: The role of postoperative irradiation in the treatment of oligodendroglioma. Int J Radiat Oncol Biol Phys 30: 567-573, 1994
16. Wallner KE, Gonzales M, Sheline GE: Treatment of oligodendrogliomas with or without postoperative irradiation. J Neurosurg 68: 684-688, 1988
17. Olson JD, Riedel E, DeAngelis LM: Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54: 1442-1448, 2000
18. Allison RR, Schulsinger A, Vongtama V et al.: Radiation and chemotherapy improve outcome in oligodendroglioma. Int J Radiat Oncol Biol Phys 37: 399-403, 1997
19. Jeremic B, Shibamoto Y, Grujicic D et al.: Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma. A phase II study. Radiother Oncol 49: 49-54, 1998
20. Cairncross JG: Aggressive oligodendroglioma: a chemosensitive tumor. Recent Results Cancer Res 135: 127-133, 1994
21. Eyre HJ, Crowley JJ, Townsend JJ et al.: A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. J Neurosurg 78: 909-914, 1993
22. Cairncross JG, Macdonald DR: Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 23: 360-364, 1988
23. Cairncross JG, Ueki K, Zlatescu MC et al.: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90: 1473-1479, 1998
24. van den Bent MJ, Keime-Guibert F, Brandes AA et al.: Temozolomide chemotherapy in recurrent oligodendroglioma. Neurology 57: 340-342, 2001
25. Chinot OL, Honore S, Dufour H et al.: Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy. J Clin Oncol 19: 2449-2455, 2001
26. Leighton C, Fisher B, Bauman G et al.: Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 15: 1294-1301, 1997
27. Henderson KH, Shaw EG: Randomized trials of radiation therapy in adult low-grade gliomas. Semin Radiat Oncol 11: 145-151, 2001